HIGHLIGHTS
- What: The aim of this paper is to analyze the available evidence on metformin in cancer therapy, highlighting its mode of action, clinical outcomes, and potential as an adjuvant therapy.
- Who: Ziyue Liang from the University of Glasgow, Glasgow, QQ, United Kingdom have published the research: Metformin: exploring its potential as an anticancer drug, in the : Proceedings of the 4th International Conference on Biological Engineering and Medical Science
- Future: This paper will also present the shortcomings and barriers in this research as well as possible future directions. For future research directions large-scale . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.